BioSmart Co.,Ltd. (KOSDAQ:038460)
3,025.00
-40.00 (-1.31%)
Last updated: Mar 28, 2025
BioSmart Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Operating Revenue | 484,310 | 456,164 | 391,822 | 189,183 | 166,429 | Upgrade
|
Other Revenue | -0 | -0 | - | - | - | Upgrade
|
Revenue | 484,310 | 456,164 | 391,822 | 189,183 | 166,429 | Upgrade
|
Revenue Growth (YoY) | 6.17% | 16.42% | 107.11% | 13.67% | 4.69% | Upgrade
|
Cost of Revenue | 402,047 | 377,159 | 315,092 | 120,747 | 107,523 | Upgrade
|
Gross Profit | 82,262 | 79,006 | 76,729 | 68,436 | 58,906 | Upgrade
|
Selling, General & Admin | 58,515 | 62,452 | 61,167 | 56,114 | 55,352 | Upgrade
|
Research & Development | 680.12 | 1,341 | 1,168 | 426.86 | 1,029 | Upgrade
|
Other Operating Expenses | 728.38 | 705.79 | 1,023 | 696.17 | 759.78 | Upgrade
|
Operating Expenses | 62,802 | 69,248 | 67,428 | 60,477 | 60,391 | Upgrade
|
Operating Income | 19,460 | 9,758 | 9,302 | 7,960 | -1,486 | Upgrade
|
Interest Expense | -4,638 | -5,962 | -4,396 | -2,041 | -1,219 | Upgrade
|
Interest & Investment Income | 846.24 | 618.81 | 461.18 | 172.16 | 516.41 | Upgrade
|
Earnings From Equity Investments | 2,228 | -20.7 | 321.76 | -3,042 | -39.28 | Upgrade
|
Currency Exchange Gain (Loss) | 66.64 | -37.47 | -131.2 | -336.59 | 266.6 | Upgrade
|
Other Non Operating Income (Expenses) | -4,565 | 3,228 | -3,657 | 1,679 | -756.53 | Upgrade
|
EBT Excluding Unusual Items | 13,399 | 7,585 | 1,901 | 4,391 | -2,717 | Upgrade
|
Gain (Loss) on Sale of Investments | 913.72 | 15,880 | -102.27 | 283.56 | -416.34 | Upgrade
|
Gain (Loss) on Sale of Assets | -315.55 | -1,014 | 143.33 | -341.1 | -105.44 | Upgrade
|
Asset Writedown | -1,896 | -1,355 | -3.29 | -3,042 | -6,230 | Upgrade
|
Other Unusual Items | -5,041 | 82.03 | 17.27 | 49.25 | - | Upgrade
|
Pretax Income | 7,061 | 21,178 | 1,956 | 1,341 | -9,469 | Upgrade
|
Income Tax Expense | 6,005 | 4,998 | 3,137 | 707.1 | 2,036 | Upgrade
|
Earnings From Continuing Operations | 1,055 | 16,179 | -1,182 | 633.8 | -11,505 | Upgrade
|
Minority Interest in Earnings | -928.13 | 1,728 | 1,903 | 758.67 | 2,768 | Upgrade
|
Net Income | 127.17 | 17,907 | 721.31 | 1,392 | -8,737 | Upgrade
|
Net Income to Common | 127.17 | 17,907 | 721.31 | 1,392 | -8,737 | Upgrade
|
Net Income Growth | -99.29% | 2382.56% | -48.20% | - | - | Upgrade
|
Shares Outstanding (Basic) | 21 | 20 | 19 | 19 | 19 | Upgrade
|
Shares Outstanding (Diluted) | 21 | 32 | 19 | 19 | 19 | Upgrade
|
Shares Change (YoY) | -34.07% | 67.46% | - | -0.79% | -3.66% | Upgrade
|
EPS (Basic) | 6.00 | 915.00 | 37.57 | 72.53 | -451.51 | Upgrade
|
EPS (Diluted) | 6.00 | 557.00 | 37.57 | 72.53 | -452.00 | Upgrade
|
EPS Growth | -98.92% | 1382.47% | -48.20% | - | - | Upgrade
|
Free Cash Flow | -3,213 | -1,947 | 1,930 | -4,129 | -15,849 | Upgrade
|
Free Cash Flow Per Share | -151.61 | -60.58 | 100.52 | -215.07 | -819.09 | Upgrade
|
Gross Margin | 16.98% | 17.32% | 19.58% | 36.18% | 35.39% | Upgrade
|
Operating Margin | 4.02% | 2.14% | 2.37% | 4.21% | -0.89% | Upgrade
|
Profit Margin | 0.03% | 3.93% | 0.18% | 0.74% | -5.25% | Upgrade
|
Free Cash Flow Margin | -0.66% | -0.43% | 0.49% | -2.18% | -9.52% | Upgrade
|
EBITDA | 27,664 | 18,247 | 18,874 | 13,591 | 3,828 | Upgrade
|
EBITDA Margin | 5.71% | 4.00% | 4.82% | 7.18% | 2.30% | Upgrade
|
D&A For EBITDA | 8,204 | 8,490 | 9,572 | 5,632 | 5,314 | Upgrade
|
EBIT | 19,460 | 9,758 | 9,302 | 7,960 | -1,486 | Upgrade
|
EBIT Margin | 4.02% | 2.14% | 2.37% | 4.21% | -0.89% | Upgrade
|
Effective Tax Rate | 85.05% | 23.60% | 160.43% | 52.73% | - | Upgrade
|
Advertising Expenses | 948.51 | 2,704 | 2,369 | 2,597 | 2,720 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.